fluorouracil has been researched along with Cruveilhier-Baumgarten Syndrome in 6 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Cruveilhier-Baumgarten Syndrome: Liver cirrhosis with intrahepatic portal obstruction, HYPERTENSION, and patent UMBILICAL VEINS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 46-year-old man with cancer of the sigmoid colon with hepatic metastasis underwent sigmoidectomy, partial hepatectomy, and cholecystectomy in May 2008." | 1.39 | [A case of portal hypertension after 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) chemotherapy]. ( Aishima, S; Gushima, T; Maruoka, S; Matsuura, T; Ogata, H; Takahashi, K; Takasaki, S; Tanaka, R, 2013) |
| "Furthermore pathogenesis of liver fibrosis is not well known." | 1.39 | A case of liver fibrosis with splenomegaly after oxaliplatin-based adjuvant chemotherapy for colon cancer. ( Jeong, HY; Kang, DY; Kang, GH; Kim, SH; Lee, BS; Lee, ES; Lee, HY; Moon, HS; Sung, JK, 2013) |
| "A case of hepatocellular carcinoma (HCC) complicated by tumor thrombosis of the main trunk is presented." | 1.31 | Chemotherapy for hepatocellular carcinoma with portal hypertension due to tumor thrombus. ( Ando, E; Fukumori, K; Sata, M; Sumie, S; Tanaka, M; Yamashita, F; Yano, Y, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, J | 1 |
| Zhang, X | 1 |
| Cui, R | 1 |
| Zhang, J | 2 |
| Wang, Z | 1 |
| Jia, Y | 1 |
| Miao, R | 1 |
| Dong, Y | 1 |
| Ma, X | 1 |
| Fan, H | 1 |
| Wang, H | 1 |
| Ren, L | 1 |
| Li, Y | 1 |
| Niu, W | 1 |
| Qu, K | 1 |
| Liu, C | 1 |
| Ogata, H | 1 |
| Gushima, T | 1 |
| Maruoka, S | 1 |
| Takasaki, S | 1 |
| Tanaka, R | 1 |
| Matsuura, T | 1 |
| Aishima, S | 1 |
| Takahashi, K | 1 |
| Kang, GH | 1 |
| Moon, HS | 1 |
| Lee, ES | 1 |
| Kim, SH | 1 |
| Sung, JK | 1 |
| Lee, BS | 1 |
| Jeong, HY | 1 |
| Lee, HY | 1 |
| Kang, DY | 1 |
| Lawal, TO | 1 |
| Farris, AB | 1 |
| El-Rayes, BF | 1 |
| Subramanian, RM | 1 |
| Kim, HS | 1 |
| Ayav, A | 1 |
| Habib, N | 1 |
| Jiao, LR | 1 |
| Ando, E | 1 |
| Tanaka, M | 1 |
| Yamashita, F | 1 |
| Fukumori, K | 1 |
| Sumie, S | 1 |
| Yano, Y | 1 |
| Sata, M | 1 |
6 other studies available for fluorouracil and Cruveilhier-Baumgarten Syndrome
| Article | Year |
|---|---|
Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization.
Topics: Alanine Transaminase; Alkaline Phosphatase; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy | 2019 |
[A case of portal hypertension after 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) chemotherapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 2013 |
A case of liver fibrosis with splenomegaly after oxaliplatin-based adjuvant chemotherapy for colon cancer.
Topics: Actins; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Coloni | 2013 |
Oxaliplatin-induced hepatoportal sclerosis, portal hypertension, and variceal bleeding successfully treated with transjugular intrahepatic portosystemic shunt.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colo | 2012 |
Portal hypertension secondary to 90Yttrium microspheres: an unknown complication.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capeci | 2005 |
Chemotherapy for hepatocellular carcinoma with portal hypertension due to tumor thrombus.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Female; | 2000 |